David Kirn plan to sell securities of 4D Molecular Therapeutics, Inc. under Form 144

David Kirn filed Form 144 to notify SEC of plan to sell 1922 units of 4D Molecular Therapeutics, Inc. securities around 2026-06-01, with aggregate market value of $18,662.62. The total outstanding units is 52276254.0. The amount planned to be sold represents 0.00% of total outstanding units;